Target intelligence / Profile preview

Histone cell cycle regulator pseudogene 1 (HIRAP1)

Target
HIRAP1
Molecular classification
Other, Pseudogene
01

Overview

Histone cell cycle regulator pseudogene 1 (HIRAP1) is annotated as a *pseudogene* rather than a protein-coding gene or validated functional RNA. Pseudogenes are genomic DNA sequences similar to known genes but generally lack the ability to encode functional proteins due to mutations or truncations and are not considered therapeutic targets such as receptors, enzymes, or transporters[1]. HIRAP1 does not have known functional roles or associations with disease and is just a remnant sequence related to the "HIR" family (histone cell cycle regulators) but with no established biological or clinical impact. It is not involved in drug interactions, mechanisms of action, or biomarker functions. This gene is not a validated target for drug development and should not be classified with molecular families like receptors, ion channels, or transcription factors. There is no evidence that "HIRAP1" encodes an active protein or has biological activity; it is a pseudogene and thus *is not considered a therapeutic target*. Its inclusion in target lists for drug discovery/biology is likely incorrect or misleading. The canonical name should be "Histone cell cycle regulator pseudogene 1" and the canonical abbreviation "HIRAP1". There is no known disease association, drug interaction, or safety concern related to this pseudogene[1].

Other names
HIRAP1HIR histone cell cycle regulation defective homolog A pseudogene 1

Beyond the preview

Go deeper on Histone cell cycle regulator pseudogene 1 (HIRAP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Histone cell cycle regulator pseudogene 1 (HIRAP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call